These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7794794)

  • 1. Insulin-like growth factor II overexpression in myoblasts induces phenotypic changes typical of the malignant phenotype.
    Minniti CP; Luan D; O'Grady C; Rosenfeld RG; Oh Y; Helman LJ
    Cell Growth Differ; 1995 Mar; 6(3):263-9. PubMed ID: 7794794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation.
    Quinn LS; Steinmetz B; Maas A; Ong L; Kaleko M
    J Cell Physiol; 1994 Jun; 159(3):387-98. PubMed ID: 8188756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
    Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
    J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.
    El-Badry OM; Minniti C; Kohn EC; Houghton PJ; Daughaday WH; Helman LJ
    Cell Growth Differ; 1990 Jul; 1(7):325-31. PubMed ID: 2177632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.
    Layne MD; Farmer SR
    Exp Cell Res; 1999 May; 249(1):177-87. PubMed ID: 10328964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of insulin-like growth factor-II in mouse embryonic stem cells promotes myogenic differentiation.
    Prelle K; Wobus AM; Krebs O; Blum WF; Wolf E
    Biochem Biophys Res Commun; 2000 Nov; 277(3):631-8. PubMed ID: 11062005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mRNA for the insulin-like growth factors and their receptors in human preimplantation embryos.
    Lighten AD; Hardy K; Winston RM; Moore GE
    Mol Reprod Dev; 1997 Jun; 47(2):134-9. PubMed ID: 9136113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells.
    Eicher DJ; Moats-Staats BM; Stiles AD; D'Ercole AJ
    Dev Genet; 1993; 14(3):194-203. PubMed ID: 8358865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts.
    Meadows KA; Holly JM; Stewart CE
    J Cell Physiol; 2000 Jun; 183(3):330-7. PubMed ID: 10797307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
    Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
    Fottner Ch; Hoeflich A; Wolf E; Weber MM
    Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells.
    Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z
    Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent inhibition of myoblast differentiation by overexpression of the type-1 insulin-like growth factor receptor.
    Quinn LS; Ehsan M; Steinmetz B; Kaleko M
    J Cell Physiol; 1993 Sep; 156(3):453-61. PubMed ID: 7689569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new marker for rhabdomyosarcoma. Insulin-like growth factor II.
    Yun K
    Lab Invest; 1992 Nov; 67(5):653-64. PubMed ID: 1434543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
    Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
    J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation.
    Quinn LS; Roh JS
    Exp Cell Res; 1993 Oct; 208(2):504-8. PubMed ID: 8375479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis.
    Damon SE; Haugk KL; Swisshelm K; Quinn LS
    Exp Cell Res; 1997 Nov; 237(1):192-5. PubMed ID: 9417882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of insulin-like growth factor-II induces accelerated myoblast differentiation.
    Stewart CE; James PL; Fant ME; Rotwein P
    J Cell Physiol; 1996 Oct; 169(1):23-32. PubMed ID: 8841419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.